Prostate carcinoma
|
0.090 |
Biomarker
|
disease |
BEFREE |
This study aims to develop and evaluate oleuropein loaded surface functionalized folate-targeted - PEG liposomes for the effective management of prostate cancer in an animal model.
|
30710640 |
2019 |
Prostate carcinoma
|
0.090 |
Biomarker
|
disease |
BEFREE |
Evaluation of a novel GRPR antagonist for prostate cancer PET imaging: [<sup>64</sup>Cu]-DOTHA<sub>2</sub>-PEG-RM26.
|
29154145 |
2018 |
Prostate carcinoma
|
0.090 |
Biomarker
|
disease |
BEFREE |
In the present study, a tumor-targeting cationic gene vector, known as the disulfide cross-linked arginine-aspartic acid peptide modified by HAIYPRH (T7) peptide (CRD-PEG-T7), was designed for targeted delivery of plasmid DNA (pDNA) for gene therapy of prostate cancer (PCa).
|
30464450 |
2018 |
Prostate carcinoma
|
0.090 |
AlteredExpression
|
disease |
BEFREE |
We prospectively administered a battery of geriatric (MNA, GDS, Get up and Go Test, CIRS-G, ADL, IADL, MMSE), toxicity (IPSS; IIEF 5), and QoL (QLQ C30) screening tests in 100 elderly patients before and two months after prostate cancer radiotherapy (NCT 02876237).
|
29630602 |
2018 |
Prostate carcinoma
|
0.090 |
Biomarker
|
disease |
BEFREE |
Therefore, small, short-circulating (10 kDa, ∼7 nm, t<sub>1/2</sub> ∼ 1 h) and larger, longer-circulating (40 kDa, ∼13 nm, t<sub>1/2</sub> ∼ 13 h) riboflavin-targeted branched PEG polymers were synthesized, and their biodistribution and target site accumulation were evaluated in mice bearing angiogenic squamous cell carcinoma (A431) and desmoplastic prostate cancer (PC3) xenografts.
|
28715227 |
2017 |
Prostate carcinoma
|
0.090 |
Biomarker
|
disease |
BEFREE |
Cellax polymeric conjugates consisting of carboxymethyl cellulose functionalized with PEG and hydrophobic anticancer drugs, such as cabazitaxel (coined Cellax-CBZ), have been shown to have high potency against several oncology targets, including prostate cancer.
|
28945432 |
2017 |
Prostate carcinoma
|
0.090 |
Biomarker
|
disease |
BEFREE |
Here, we synthesized a BBN-modified gadolinium oxide (Gd<sub>2</sub>O<sub>3</sub>) nanoprobe containing fluorescein (Gd<sub>2</sub>O<sub>3</sub>-5(6)-carboxyfluorescein [FI]-polyethylene glycol [PEG]-BBN) for targeted magnetic resonance (MR)/optical dual-modality imaging of PC.
|
28979118 |
2017 |
Prostate carcinoma
|
0.090 |
AlteredExpression
|
disease |
BEFREE |
A truncated version of the CCN1/CYR61 gene promoter, tCCN1-Prom, was more active than progression elevated gene-3 promoter (PEG-Prom) in regulating transformation-selective transgene expression in CaP and oncogene-transformed rat embryo cells.
|
25926554 |
2015 |
Prostate carcinoma
|
0.090 |
AlteredExpression
|
disease |
BEFREE |
The efficacy of the PEG-Prom as part of a cancer gene therapeutic regimen is further documented by in vivo experiments in which PEG-Prom-controlled expression of an apoptosis-inducing gene completely inhibited prostate cancer xenograft growth in nude mice.
|
15647352 |
2005 |